2Xideas’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
2Xideas's HALO Position: Q2 2026 in Review
2Xideas reduced its Halozyme (HALO) stake by 4.2% in Q2 2026, selling an estimated $266K and leaving 87,769 shares worth $6.87M. The position accounts for 2.96% of the portfolio, ranked #7.
2Xideas first reported a position in HALO in Q2 2022 and has held it in 17 quarters since. The position peaked at $26.1M in Q2 2024. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- 2Xideas held 87,769 shares of Halozyme worth $6.87M as of Q2 2026.
- 2Xideas sold 3,894 Halozyme shares in Q2 2026, an estimated $266K.
- Halozyme made up 2.96% of 2Xideas's portfolio in Q2 2026, its #7 holding.
- 2Xideas first reported a position in Halozyme in Q2 2022 and has held it in 17 quarters since.
- 2Xideas's Halozyme position peaked at $26.1M in Q2 2024.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on 2Xideas's 13F filing for Q2 2026, filed 14 Aug 2026.